Cannabinoid monoterpene based pharmaceutical topical composition for musculoskeletal pain
US12357587B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 20, 2022 |
| Grant date | Jul 15, 2025 |
| Priority date | — |
| Expiry date | Oct 31, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2236/35
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A topical pain relief composition has a base with a mixture of various components such as, but not limited to, a base, d-limonene, cannabinoids or a derivative thereof, ashwagandha extracts and dimethyl sulfoxide (DMSO).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.